SOLTI-1801. Analysis of the efficacy of CDK4/6 inhibitors in combination with hormonal treatment in luminal breast cancer in relation to the intrinsic subtype and markers of immunity (CDK-PREDICT)
Pablo Tolosa1, Tomás Pascual2, Cristina Hernando3, Sonia Servitja4, María Fernández Abad5, Rafael Villanueva6, Fernando Henao7, Javier Benítez8, Laura Lema9, Mario Martínez10, Yolanda Ruano11, Lucía Parrilla10, Alejandra Bernardini12, Ana María Roncero13, Laia Paré14, Jordi Canes14, Fernando Salvador14, Patricia Villagrasa14, Aleix Prat15 and Eva Ciruelos16
Communication in congress
ePoster
SABCS
2020